STRATA Skin Sciences, Inc. (SSKN)

STRATA Skin Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.91	7.26	6.78	5.43	12.59
Cash & Short-Term Investments	7.91	7.26	6.78	5.43	12.59
Cash Growth	8.97%	7.03%	24.84%	-56.83%	18.69%
Receivables	4.12	5.25	4.44	4.47	3.43
Inventory	2.81	2.25	2.67	3.1	3.49
Prepaid Expenses	0.75	0.5	0.31	0.69	0.46
Restricted Cash	-	1.33	1.33	1.36	-
Total Current Assets	15.6	16.6	15.54	15.05	19.97
Property, Plant & Equipment	9.88	11.33	12.4	10.93	7.52
Goodwill	1.43	1.43	6.52	8.8	8.8
Other Intangible Assets	3.38	5.35	7.32	17.39	10.08
Other Long-Term Assets	0.23	0.23	0.23	0.1	0.22
Total Assets	30.52	34.93	42.02	52.27	46.59

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.76	2.43	3.34	3.43	2.82
Accrued Expenses	6	7.15	6.13	6.42	6.32
Current Portion of Long-Term Debt	15.35	-	-	-	-
Current Portion of Leases	0.23	0.33	0.35	0.36	0.32
Current Unearned Revenue	2.25	2.24	2.12	2.78	3.29
Other Current Liabilities	0.16	1.24	0.23	0.45	0.06
Total Current Liabilities	26.74	13.4	12.17	13.43	12.8
Long-Term Debt	-	15.19	15.04	7.48	7.32
Long-Term Leases	0.69	0.92	0.24	0.61	0.39
Long-Term Unearned Revenue	0.18	0.35	0.55	0.31	0.4
Long-Term Deferred Tax Liabilities	-	-	0.19	0.31	0.27
Other Long-Term Liabilities	-	0.1	1.14	8.31	-
Total Liabilities	27.61	29.96	29.33	30.44	21.18

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0	0	0.04	0.03
Additional Paid-In Capital	257.31	253.11	250.74	249.02	247.06
Retained Earnings	-254.41	-248.14	-238.06	-227.23	-221.68
Total Common Equity	2.91	4.97	12.69	21.83	25.41
Shareholders' Equity	2.91	4.97	12.69	21.83	25.41
Total Liabilities & Equity	30.52	34.93	42.02	52.27	46.59

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.27	16.44	15.63	8.44	8.03
Net Cash (Debt)	-8.36	-9.18	-8.85	-3.01	4.56
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.80	-2.41	-2.53	-0.87	1.34
Filing Date Shares Outstanding	5.89	4.17	3.51	3.49	3.47
Total Common Shares Outstanding	5.89	4.17	3.51	3.47	3.44
Working Capital	-11.14	3.2	3.37	1.63	7.17
Book Value Per Share	0.49	1.19	3.62	6.29	7.40
Tangible Book Value	-1.9	-1.81	-1.15	-4.37	6.53
Tangible Book Value Per Share	-0.32	-0.43	-0.33	-1.26	1.90
Machinery	37.45	36.12	35.86	31.77	26.4
Leasehold Improvements	0.08	0.09	0.2	0.14	0.25

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error